Tag: SARS-CoV-2
Gilead Sciences gets Veklury FDA approval for non-hospitalized Covid-19 patients
Gilead Sciences has secured expedited approval from the US Food and Drug Administration (FDA) for its nucleotide analog Veklury (remdesivir) for the treatment of non-hospitalized ... Read More
Biocon gets license for Adagio Therapeutics’ ADG20 for Covid-19 treatment
Biocon Limited said that its subsidiary Biocon Biologics has been given an exclusive license from Adagio Therapeutics, a US-based biotech company, for manufacturing and commercializing ... Read More
Bharat Biotech reports positive Covaxin phase 3 results with 77.8% efficacy
Covaxin phase 3 results : Bharat Biotech, an Indian biotech company, said that Covaxin, its whole virion inactivated vaccine against SARS-CoV2, has demonstrated efficacy of ... Read More
Seegene gets $4.8m order for supplying Covid-19 diagnostic kits to Kuwait
Seegene, a South Korean molecular diagnostics company has been given an order worth more than $4.8 million for supplying its Allplex SARS-CoV-2 Assay Covid-19 diagnostic ... Read More
DCGI gives emergency use approval for DRDO’s anti-COVID drug 2-DG
The Drugs Controller General of India (DCGI) has given emergency use approval for 2-deoxy-D-glucose (2-DG) of Defence Research and Development Organisation (DRDO) for the treatment ... Read More
CORAT begins COR-101 clinical trial in hospitalized Covid patients
CORAT Therapeutics said that it has begun a phase 1b/2 clinical trial of its antibody drug candidate COR-101 for the treatment of hospitalized Covid-19 patients. ... Read More
Sound Pharmaceuticals gets NIH grant for Covid-19 candidate SPI-1005
Sound Pharmaceuticals has secured a grant of $3.1 million for supporting the evaluation of its COVID-19 treatment candidate SPI-1005 in two phase 2 clinical trials ... Read More
Grifols phase 3 Covid-19 trial of hyperimmune globulins fails to meet objective
Spanish pharma company Grifols said that the phase 3 ITAC clinical trial assessing hyperimmune globulins as a treatment for patients hospitalized with Covid-19 has failed ... Read More
Janssen Covid‑19 vaccine gets conditional marketing authorization in EU
The European Commission has granted a conditional marketing authorization (CMA) for the single dose Janssen Covid‑19 vaccine developed by the Janssen Pharmaceutical Companies of Johnson ... Read More
Pfizer begins phase 1 study of Covid drug candidate PF-07321332
Pfizer said that it has initiated a phase 1 study in the US for assessing the oral antiviral therapeutic PF-07321332 against SARS-CoV-2, the virus that ... Read More